About
Technology
Issues
FAQ
Links
Official Page
A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.